Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 1/20 | 0.82 |
| ▸ | CTSL | P07711 | 1/20 | 0.82 |
| ▸ | CTSB | P07858 | 1/20 | 0.82 |
| ▸ | CXCL12 | P48061 | 10/20 | 0.82 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.80 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.73 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.73 |
| ▸ | TUBB | P07437 | 1/20 | 0.73 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.73 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.73 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.73 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.73 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.73 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.73 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.73 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.73 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.73 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.73 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.73 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30383354 | 1.00 | CAPN1 (0.82) | CAPN1CTSLCTSBCXCL12CXCR4 | |
| SCHEMBL597850 | 1.00 | CAPN1 (0.82) | CAPN1CTSLCTSBCXCL12CXCR4 | |
| SCHEMBL30383698 | 1.00 | CAPN1 (0.82) | CAPN1CTSLCTSBCXCL12CXCR4 | |
| SCHEMBL25198557 | 0.99 | CAPN1 (0.81) | CAPN1CTSLCTSBCXCL12CXCR4 | |
| Formaldehyde SCHEMBL597329 | 0.97 | CAPN1 (0.79) | CAPN1CTSLCTSBCXCL12CXCR4 | |
| SCHEMBL30384490 | 0.96 | CXCL12 (0.89) | CAPN1CTSLCTSBCXCL12CXCR4 | |
| SCHEMBL12677857 | 0.96 | CXCL12 (0.89) | CAPN1CTSLCTSBCXCL12CXCR4 | |
| SCHEMBL25193952 | 0.96 | CXCL12 (0.89) | CAPN1CTSLCTSBCXCL12CXCR4 | |
| SCHEMBL5598901 | 0.91 | CXCL12 (0.82) | CXCL12CXCR4TUBB4ATUBBTUBA3C | |
| SCHEMBL5598905 | 0.91 | CXCL12 (0.82) | CXCL12CXCR4TUBB4ATUBBTUBA3C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2170796-B1 | 3-(4-HYDROXY-3-METHOXYPHENYL)-1-(4-HYDROXYPHENYL)-1-PROPANONE AND USE THEREOF AS AN ANTIMICROBIAL ACTIVE INGREDIENT | SYMRISE AG (DE) | 2012-09-12 | — | — | EP | claimed |
| US-8115033-B2 | 3-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-1-propanone and use thereof as an antimicrobial active ingredient | SYMRISE AG (DE) | 2012-02-14 | — | — | US | claimed |
| US-20100254925-A1 | 3-(4-HYDROXY-3-METHOXYPHENYL)-1-(4-HYDROXYPHENYL)-1-PROPANONE AND USE THEREOF AS AN ANTIMICROBIAL ACTIVE INGREDIENT | SYMRISE GMBH & CO. KG (DE) | 2010-10-07 | — | — | US | claimed |
| EP-2170796-A1 | 3-(4-HYDROXY-3-METHOXYPHENYL)-1-(4-HYDROXYPHENYL)-1-PROPANONE AND USE THEREOF AS AN ANTIMICROBIAL ACTIVE INGREDIENT | Symrise GmbH & Co. KG (DE) | 2010-04-07 | — | — | EP | claimed |
| WO-2009013166-A1 | 3-(4-HYDROXY-3-METHOXYPHENYL)-1-(4-HYDROXYPHENYL)-1-PROPANONE AND USE THEREOF AS AN ANTIMICROBIAL ACTIVE INGREDIENT | SYMRISE GMBH & CO. KG (DE) | 2009-01-29 | — | — | WO | claimed |
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | YEWSAVIN INC (US) | 2026-01-15 | — | — | US | disclosed |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | YewSavin, Inc. (US) | 2025-07-01 | — | — | US | disclosed |
| US-20230190679-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-06-22 | — | — | US | disclosed |
| WO-2023086388-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-05-19 | — | — | WO | disclosed |
| US-11046657-B2 | Pyrimidinone derivatives and uses thereof to neutralize the biological activity of chemokines | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2021-06-29 | — | — | US | disclosed |
| US-11046657-B2 | Pyrimidinone derivatives and uses thereof to neutralize the biological activity of chemokines | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2021-06-29 | — | — | US | disclosed |
| US-20200181093-A1 | Pyrimidinone Derivatives and Uses Thereof to Neutralize the Biological Activity of Chemokines | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS (FR) | 2020-06-11 | — | — | US | disclosed |
| EP-2090289-A2 | Cosmetic or dermatological preparations with a 3-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxphenyl)-propan-1-on content and ethylhexyl-2-cyano-3, 3-diphenylacrylate | Beiersdorf AG (DE) | 2009-08-19 | — | — | EP | disclosed |
| EP-2090301-A1 | 3-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-1-propanon und its use in cosmetic and pharmaceutical preparations | Symrise GmbH & Co. KG (DE) | 2009-08-19 | — | — | EP | disclosed |
| EP-2090286-A2 | Cosmetic or dermatological preparations with a 3-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxphenyl)-propan-1-on content and one or more emulgators | Beiersdorf AG (DE) | 2009-08-19 | — | — | EP | disclosed |
| EP-2090288-A2 | Cosmetic or dermatological preparations with a 3-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxphenyl)-propan-1-on content and one or more cinnamon acid derivatives | Beiersdorf AG (DE) | 2009-08-19 | — | — | EP | disclosed |
| WO-2009013168-A1 | 3-(4-HYDROXY-3-METHOXYPHENYL)-1-(4-HYDROXYPHENYL)-1-PROPANONE AND ITS USE AS ANTIOXIDANT | SYMRISE GMBH & CO. KG (DE) | 2009-01-29 | — | — | WO | disclosed |
| WO-2009013166-A1 | 3-(4-HYDROXY-3-METHOXYPHENYL)-1-(4-HYDROXYPHENYL)-1-PROPANONE AND USE THEREOF AS AN ANTIMICROBIAL ACTIVE INGREDIENT | SYMRISE GMBH & CO. KG (DE) | 2009-01-29 | — | — | WO | disclosed |
| WO-2009013166-A1 | 3-(4-HYDROXY-3-METHOXYPHENYL)-1-(4-HYDROXYPHENYL)-1-PROPANONE AND USE THEREOF AS AN ANTIMICROBIAL ACTIVE INGREDIENT | SYMRISE GMBH & CO. KG (DE) | 2009-01-29 | — | — | WO | disclosed |
| WO-2007085636-A1 | REVERSIBLE THERMOCHROMIC COMPOSITIONS | CIBA HOLDING INC. (CH) | 2007-08-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200181093-A1 | Pyrimidinone Derivatives and Uses Thereof to Neutralize the Biological Activity of Chemokines | CCL5, CXCR3, CXCL10 | CAPN1 4120/4885CTSL 2430/4885CTSB 706/4885 |
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | SERPINC1, F2, F13B | CAPN1 2288/4885CTSL 357/4885CTSB 51/4885 |
| US-11046657-B2 | Pyrimidinone derivatives and uses thereof to neutralize the biological activity of chemokines | CCL5, CXCR3, CXCL10 | CAPN1 4120/4885CTSL 2430/4885CTSB 706/4885 |
| US-20230190679-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | SERPINC1, SERPINE1, SERPINH1 | CAPN1 1989/4885CTSL 310/4885CTSB 60/4885 |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | SERPINC1, SERPINE1, SERPINH1 | CAPN1 1989/4885CTSL 310/4885CTSB 60/4885 |
| US-20100254925-A1 | 3-(4-HYDROXY-3-METHOXYPHENYL)-1-(4-HYDROXYPHENYL)-1-PROPANONE AND USE THEREOF AS AN ANTIMICROBIAL ACTIVE INGREDIENT | P4HA1, HPD, CYP8B1 | CAPN1 1179/4885CTSL 370/4885CTSB 874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.